{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:27:44Z","timestamp":1793964464961,"version":"4.8.0"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0332_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Juvenile Paget disease (JPD) is an ultra-rare inherited metabolic bone disorder characterized by excessive skeletal turnover secondary to osteoprotegerin (OPG) dysfunction. Early diagnosis is important because progressive skeletal and extraskeletal complications may develop during infancy and childhood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0332_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We report a 2-month-old infant presenting with severe irritability and pain even with gentle movement, femoral swelling, and persistent hyperphosphatasemia. Skeletal survey demonstrated findings compatible with JPD. Genetic analysis identified a rare homozygous intronic\n                      <jats:italic>TNFRSF11B<\/jats:italic>\n                      variant. Pamidronate treatment resulted in marked biochemical and clinical improvement, including a marked reduction in alkaline phosphatase levels compared with baseline values, resolution of pain, and preservation of neuromotor developmental milestones during the 2-year follow-up period. Cardiovascular evaluation, vascular imaging, and ophthalmologic examinations revealed no abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0332_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the diagnostic challenges of early-onset JPD and supports the importance of careful clinical, radiologic, and genetic evaluation in infants with persistent hyperphosphatasemia and skeletal abnormalities. Although early bisphosphonate therapy effectively improved skeletal disease activity, extraskeletal manifestations may still occur during follow-up, highlighting the need for continued long-term surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0332","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:59:27Z","timestamp":1785398367000},"page":"1200-1204","source":"Crossref","is-referenced-by-count":0,"title":["Early-onset juvenile Paget disease associated with a homozygous intronic\n                    <i>TNFRSF11B<\/i>\n                    variant: a 2-year follow-up"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6199-1704","authenticated-orcid":false,"given":"Rabia","family":"Meral","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology , Necip Faz\u0131l City Hospital , Kahramanmara\u015f , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"G\u00f6ko\u011flu","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics , Necip Faz\u0131l City Hospital , Kahramanmara\u015f , T\u00fcrkiye"},{"name":"Department of Medical Genetics , Antalya City Hospital , Antalya , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2026110611002044067_j_jpem-2026-0332_ref_001","doi-asserted-by":"crossref","unstructured":"Blair, JM, Zheng, Y, Dunstan, CR. RANK ligand. Int J Biochem Cell Biol 2007;39:1077\u201381. https:\/\/doi.org\/10.1016\/j.biocel.2006.11.008.","DOI":"10.1016\/j.biocel.2006.11.008"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_002","doi-asserted-by":"crossref","unstructured":"Polyzos, SA, Cundy, T, Mantzoros, CS. Juvenile Paget disease. Metabolism 2018;80:15\u201326. https:\/\/doi.org\/10.1016\/j.metabol.2017.10.007.","DOI":"10.1016\/j.metabol.2017.10.007"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_003","doi-asserted-by":"crossref","unstructured":"Chong, B, Hegde, M, Fawkner, M, Simonet, S, Cassinelli, H, Coker, M, et al.. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J\u00a0Bone Min Res 2003;18:2095\u2013104. https:\/\/doi.org\/10.1359\/jbmr.2003.18.12.2095.","DOI":"10.1359\/jbmr.2003.18.12.2095"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_004","doi-asserted-by":"crossref","unstructured":"Bakwin, H, Eiger, MS. Fragile bones and macrocranium. J\u00a0Pediatr 1956;49:558\u201364. https:\/\/doi.org\/10.1016\/S0022-3476(56)80143-1.","DOI":"10.1016\/S0022-3476(56)80143-1"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_005","doi-asserted-by":"crossref","unstructured":"Grasemann, C, Unger, N, H\u00f6vel, M, Arweiler-Harbeck, D, Herrmann, R, Sch\u00fcndeln, MM, et al.. Loss of functional osteoprotegerin: more than a skeletal problem. J\u00a0Clin Endocrinol Metab 2017;102:210\u20139. https:\/\/doi.org\/10.1210\/jc.2016-2905.","DOI":"10.1210\/jc.2016-2905"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_006","doi-asserted-by":"crossref","unstructured":"Whyte, MP, Tau, C, McAlister, WH, Zhang, X, Novack, DV, Preliasco, V, et al.. Juvenile Paget\u2019s disease with heterozygous duplication within TNFRSF11A encoding RANK. Bone 2014;68:153\u201361. https:\/\/doi.org\/10.1016\/j.bone.2014.07.019.","DOI":"10.1016\/j.bone.2014.07.019"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_007","doi-asserted-by":"crossref","unstructured":"Kerr, NM. Ocular manifestations of juvenile Paget disease. Arch Ophthalmol 2010;128:698\u2013703. https:\/\/doi.org\/10.1001\/archophthalmol.2010.76.","DOI":"10.1001\/archophthalmol.2010.76"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_008","doi-asserted-by":"crossref","unstructured":"Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","DOI":"10.1038\/gim.2015.30"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_009","doi-asserted-by":"crossref","unstructured":"Saki, F, Karamizadeh, Z, Nasirabadi, S, Mumm, S, McAlister, WH, Whyte, MP. Juvenile Paget\u2019s disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. J\u00a0Bone Min Res 2013;28:1501\u20138. https:\/\/doi.org\/10.1002\/jbmr.1868.","DOI":"10.1002\/jbmr.1868"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_010","doi-asserted-by":"crossref","unstructured":"Simsek, S, Basoski, NM, Bravenboer, N, Zhang, X, Mumm, S, Whyte, MP, et al.. Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-\u03baB, osteoprotegerin, or sequestosome-1 gene defects. J\u00a0Clin Endocrinol Metab 2007;92:1897\u2013901. https:\/\/doi.org\/10.1210\/jc.2006-0479.","DOI":"10.1210\/jc.2006-0479"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_011","doi-asserted-by":"crossref","unstructured":"Tau, C, Mautalen, C, Casco, C, Alvarez, V, Rubinstein, M. Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy. Bone 2004;35:210\u20136. https:\/\/doi.org\/10.1016\/j.bone.2004.03.013.","DOI":"10.1016\/j.bone.2004.03.013"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_012","doi-asserted-by":"crossref","unstructured":"Cassinelli, HR, Mautalen, CA, Heinrich, JJ, Miglietta, A, Bergada, C. Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD). Bone Min 1992;19:175\u201384. https:\/\/doi.org\/10.1016\/0169-6009(92)90924-3.","DOI":"10.1016\/0169-6009(92)90924-3"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_013","doi-asserted-by":"crossref","unstructured":"Cundy, T, Wheadon, L, King, A. Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. J\u00a0Bone Min Res 2004;19:703\u201311. https:\/\/doi.org\/10.1359\/jbmr.040127.","DOI":"10.1359\/jbmr.040127"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_014","doi-asserted-by":"crossref","unstructured":"Kao, SY, Kempfle, JS, Jensen, JB, Perez-Fernandez, D, Lysaght, AC, Edge, AS, et al.. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. Neurobiol Dis 2013;56:25\u201333. https:\/\/doi.org\/10.1016\/j.nbd.2013.04.008.","DOI":"10.1016\/j.nbd.2013.04.008"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_015","doi-asserted-by":"crossref","unstructured":"Whyte, MP, Singhellakis, PN, Petersen, MB, Davies, M, Totty, WG, Mumm, S. Juvenile Paget\u2019s disease: the second reported, oldest patient is homozygous for the TNFRSF11B \u201cBalkan\u201d mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels. J\u00a0Bone Min Res 2007;22:938\u201346. https:\/\/doi.org\/10.1359\/jbmr.070307.","DOI":"10.1359\/jbmr.070307"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_016","doi-asserted-by":"crossref","unstructured":"Allen, CA, Hart, BL, Taylor, CL, Clericuzio, CL. Bilateral cavernous internal\u00a0carotid aneurysms in a child with juvenile Paget disease\u00a0and\u00a0osteoprotegerin deficiency. AJNR Am J Neuroradiol 2008;29:7\u20138. https:\/\/doi.org\/10.3174\/ajnr.A0755.","DOI":"10.3174\/ajnr.A0755"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_017","doi-asserted-by":"crossref","unstructured":"Sharif, KW, Doig, WW, Kinsella, FP. Visual impairment in a case of juvenile Paget\u2019s disease with pseudoxanthoma elasticum: an eleven year follow-up. J\u00a0Pediatr Ophthalmol Strabismus 1989;26:299\u2013302. https:\/\/doi.org\/10.3928\/0191-3913-19891101-13.","DOI":"10.3928\/0191-3913-19891101-13"},{"key":"2026110611002044067_j_jpem-2026-0332_ref_018","doi-asserted-by":"crossref","unstructured":"Horackova, J, Taslerova, R, Bayer, M, Nekvindova, J, Pavlikova, L, Horacek, JM, et al.. Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene. Orphanet J Rare Dis 2025;20:409. https:\/\/doi.org\/10.1186\/s13023-025-03804-2.","DOI":"10.1186\/s13023-025-03804-2"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0332\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:01:43Z","timestamp":1793962903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0332\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,9,14]]},"published-print":{"date-parts":[[2026,11,25]]}},"alternative-id":["10.1515\/jpem-2026-0332"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0332","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}